Higher recipient body mass index is associated with post-transplant delayed kidney graft function

Kidney International

Volumn 80, Issue 2, 2011, Pages 218-224

  Molnar, Miklos Z ^a,b   Kovesdy, Csaba P ^c,d   Mucsi, Istvan ^b,e   Bunnapradist, Suphamai ^f   Streja, Elani ^a   Krishnan, Mahesh ^g   Kalantar Zadeh, Kamyar ^a,f,h  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g DAVITA INC   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

body mass index; delayed graft function; kidney transplantation; obesity; pretransplant weight; weight reduction

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GRAFT RECIPIENT; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEGRO; OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR;

EID: 79959810835     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.114     Document Type: Article

References (60)

1. Yarlagadda SG, Coca SG, Garg AX et al. Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant 2008; 23: 2995-3003.
2. Perico N, Cattaneo D, Sayegh MH et al. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814-1827. (Pubitemid 39488068)
3. Ojo AO, Wolfe RA, Held PJ et al. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968-974. (Pubitemid 27173019)
4. Koning OH, van Bockel JH, van der Woude FJ et al. Risk factors for delayed graft function in University of Wisconsin solution preserved kidneys from multiorgan donors. European Multicenter Study Group on Organ Preservation. Transplant Proc 1995; 27: 752-753.
5. Sellers MT, Gallichio MH, Hudson SL et al. Improved outcomes in cadaveric renal allografts with pulsatile preservation. Clin Transplant 2000; 14: 543-549.
6. Gjertson DW. Impact of delayed graft function and acute rejection on graft survival. Transplant Proc 2002; 34: 2432. (Pubitemid 35299814)
7. Hassanain M, Tchervenkov J, Cantarovich M et al. Delayed graft function has an equally bad impact on deceased donor renal graft survival in both standard criteria donors and expanded criteria donors. Transplant Proc 2009; 41: 133-134.
8. Yarlagadda SG, Coca SG, Formica Jr RN et al. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant 2009; 24: 1039-1047.
9. Tapiawala SN, Tinckam KJ, Cardella CJ et al. Delayed graft function and the risk for death with a functioning graft. J Am Soc Nephrol 2010; 21: 153-161.
10. Almond PS, Matas AJ, Canafax DM. Fixed-rate reimbursement fails to cover costs for patients with delayed graft function. Pharmacotherapy 1991; 11: 126S-129S.
11. Almond PS, Troppmann C, Escobar F et al. Economic impact of delayed graft function. Transplant Proc 1991; 23: 1304.
12. Rosenthal JT, Danovitch GM, Wilkinson A et al. The high cost of delayed graft function in cadaveric renal transplantation. Transplantation 1991; 51: 1115-1118.
13. Friedman AN, Miskulin DC, Rosenberg IH et al. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis 2003; 41: 480-487. (Pubitemid 36152470)
14. Holley JL, Shapiro R, Lopatin WB et al. Obesity as a risk factor following cadaveric renal transplantation. Transplantation 1990; 49: 387-389. (Pubitemid 20088182)
15. Pirsch JD, Armbrust MJ, Knechtle SJ et al. Obesity as a risk factor following renal transplantation. Transplantation 1995; 59: 631-633.
16. Pischon T, Sharma AM. Obesity as a risk factor in renal transplant patients. Nephrol Dial Transplant 2001; 16: 14-17. (Pubitemid 32051467)
17. Ghahramani N, Reeves WB, Hollenbeak C. Association between increased body mass index, calcineurin inhibitor use, and renal graft survival. Exp Clin Transplant 2008; 6: 199-202.
18. Lentine KL, Rocca-Rey LA, Bacchi G et al. Obesity and cardiac risk after kidney transplantation: experience at one center and comprehensive literature review. Transplantation 2008; 86: 303-312.
19. Howard RJ, Thai VB, Patton PR et al. Obesity does not portend a bad outcome for kidney transplant recipients. Transplantation 2002; 73: 53-55. (Pubitemid 34094684)
20. Schold JD, Srinivas TR, Guerra G et al. A 'weight-listing' paradox for candidates of renal transplantation? Am J Transplant 2007; 7: 550-559. (Pubitemid 46376433)
21. Marcen R, Fernandez A, Pascual J et al. High body mass index and posttransplant weight gain are not risk factors for kidney graft and patient outcome. Transplant Proc 2007; 39: 2205-2207. (Pubitemid 47418219)
22. Johnson DW, Isbel NM, Brown AM et al. The effect of obesity on renal transplant outcomes. Transplantation 2002; 74: 675-681.
23. Streja E, Molnar MZ, Kovesdy CP et al. Associations of pre-transplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol 2011; e-pub ahead of print 17 March 2011.
24. Lynch RJ, Ranney DN, Shijie C et al. Obesity, surgical site infection, and outcome following renal transplantation. Ann Surg 2009; 250: 1014-1020.
25. Bennett WM, McEvoy KM, Henell KR et al. Morbid obesity does not preclude successful renal transplantation. Clin Transplant 2004; 18: 89-93. (Pubitemid 38195550)
26. Massarweh NN, Clayton JL, Mangum CA et al. High body mass index and short- and long-term renal allograft survival in adults. Transplantation 2005; 80: 1430-1434. (Pubitemid 41803625)
27. Espejo B, Torres A, Valentin M et al. Obesity favors surgical and infectious complications after renal transplantation. Transplant Proc 2003; 35: 1762-1763. (Pubitemid 37093702)
28. Yamamoto S, Hanley E, Hahn AB et al. The impact of obesity in renal transplantation: an analysis of paired cadaver kidneys. Clin Transplant 2002; 16: 252-256. (Pubitemid 34830841)
29. Gosmanov AR, Smiley DD, Robalino G et al. Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects. Am J Physiol Endocrinol Metab 2010; 299: E953-E958.
30. Lambert E, Sari CI, Dawood T et al. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010; 56: 351-358.
31. Olarte IG, Hawasli A. Kidney transplant complications and obesity. Am J Surg 2009; 197: 424-426.
32. Sharma AK, Tolani SL, Rathi GL et al. Evaluation of factors causing delayed graft function in live related donor renal transplantation. Saudi J Kidney Dis Transpl 2010; 21: 242-245.
33. Jensen H, Ladefoged J. Influence of warm and cold ischemia time on initial function and one-year survival of renal allografts. Clin Nephrol 1976; 5: 256-259.
34. Gentil MA, Alcaide MP, Algarra GR et al. Impact of delayed graft function on cadaveric kidney transplant outcome. Transplant Proc 2003; 35: 689-691. (Pubitemid 36338116)
35. Arias M. Impact of the delayed graft function in hypersensitized kidney transplant patients. Transplant Proc 2003; 35: 1655-1657. (Pubitemid 37093661)
36. Boom H, Mallat MJ, de Fijter JW et al. Delayed graft function influences renal function, but not survival. Kidney Int 2000; 58: 859-866. (Pubitemid 30620036)
37. Marcen R, Orofino L, Pascual J et al. Delayed graft function does not reduce the survival of renal transplant allografts. Transplantation 1998; 66: 461-466. (Pubitemid 28415371)
38. Chang SH, Coates PT, McDonald SP. Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation 2007; 84: 981-987. (Pubitemid 350287379)
39. Balamuthusamy S, Paramesh A, Zhang R et al. The effects of body mass index on graft survival in adult recipients transplanted with single pediatric kidneys. Am J Nephrol 2009; 29: 94-101.
40. Zaydfudim V, Feurer ID, Moore DR et al. Pre-transplant overweight and obesity do not affect physical quality of life after kidney transplantation. J Am Coll Surg 2010; 210: 336-344.
41. Darvall KA, Sam RC, Silverman SH et al. Obesity and thrombosis. Eur J Vasc Endovasc Surg 2007; 33: 223-233. (Pubitemid 46076268)
42. Beijers HJ, Ferreira I, Spronk HM et al. Body composition as determinant of thrombin generation in plasma: the Hoorn study. Arterioscler Thromb Vasc Biol 2010; 30: 2639-2647.
43. Ay L, Kopp HP, Brix JM et al. Thrombin generation in morbid obesity: significant reduction after weight loss. J Thromb Haemost 2010; 8: 759-765.
44. Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med 2005; 118: 978-980. (Pubitemid 41297761)
45. Casserly LF, Dember LM. Thrombosis in end-stage renal disease. Semin Dial 2003; 16: 245-256. (Pubitemid 37363225)
46. McCall SJ, Tuttle-Newhall JE, Howell DN et al. Prognostic significance of microvascular thrombosis in donor kidney allograft biopsies. Transplantation 2003; 75: 1847-1852. (Pubitemid 36734641)
47. Postorino M, Marino C, Tripepi G et al. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009; 53: 1265-1272.
48. Noori N, Kopple JD, Kovesdy CP et al. Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 2010; 5: 2258-2268.
49. Noori N, Kovesdy CP, Dukkipati R et al. Survival predictability of lean and fat mass in men and women undergoing maintenance hemodialysis. Am J Clin Nutr 2010; 92: 1060-1070.
50. Locatelli F, Fouque D, Heimburger O et al. Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant 2002; 17: 563-572. (Pubitemid 34308809)
51. Miller JE, Kovesdy CP, Norris KC et al. Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients. Am J Nephrol 2010; 32: 403-413.
52. Kovesdy CP, Czira ME, Rudas A et al. Body mass index, waist circumference and mortality in kidney transplant recipients. Am J Transplant 2010; 10: 2644-2651.
53. Kopple JD, Zhu X, Lew NL et al. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 1999; 56: 1136-1148. (Pubitemid 29411743)
54. Kalantar-Zadeh K, Streja E, Kovesdy CP et al. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc 2010; 85: 991-1001.
55. Molnar MZ, Lukowsky LR, Streja E et al. Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease. J Hypertens 2010; 28: 2475-2484.
56. Miller JE, Kovesdy CP, Nissenson AR et al. Association of hemodialysis treatment time and dose with mortality: the role of race and gender. Am J Kidney Dis 2010; 55: 100-112.
57. Kalantar-Zadeh K, Miller JE, Kovesdy CP et al. Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients. J Bone Miner Res 2010; 25: 2448-2458.
58. Molnar MZ, Streja E, Kovesdy CP et al. Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant 2011; 11: 725-736.
59. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N et al. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 2005; 20: 1880-1888. (Pubitemid 41222603)
60. Shinaberger CS, Greenland S, Kopple JD et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 2008; 88: 1511-1518.